Table 4 Absolute values and changes in HOMA-IR, fasting blood glucose and insulin in each treatment group

From: Effect of experimental hookworm infection on insulin resistance in people at risk of type 2 diabetes

HOMA-IR (units), Median and IQR (n)

 

Baseline

6 months

Δ6 mo.

12 months

Δ12 mo.

18 months

Δ18 mo.

24 months

Δ24 mo.

Placebo

2.2

2.6

−0.2

2.9

+0.8

2.0

−0.2

2.0

−0.3

2.0–2.6 (n = 12)

2.1–3.1 (n = 12)

−0.6 to 1.0

1.8–4.2 (n = 9)

−0.7 to 2.3

1.6–3.8 (n = 8)

−0.9 to 2.3

1.4–2.7 (n = 6)

−0.8 to 0.6

L3-20

3.0

2.3

−0.6

1.8a

−1.1b

1.6

−1.5

2.1a

−0.8

2.3–3.5 (n = 13)

1.5–3.2 (n = 11)

1.9 to −0.1

1.7–2.5 (n = 11)

−1.5 to −0.5

0.9–3.0 (n = 8)

−1.8 to −0.1

1.5–2.3 (n = 7)

−1.3 to −0.4

L3-40

2.4

2.1

−0.5

2.4

−0.4

2.5

−0.3

1.5

−0.5

2.1–3.0 (n = 11)

1.8–2.6 (n = 11)

−1.2 to 0.2

1.7–3.2 (n = 10)

−1.4 to 0.9

1.9–3.1 (n = 8)

−0.4 to 0.4

1.0–4.8 (n = 9)

−1.2 to 1.1

Fasting blood glucose (mmol/L), Median and IQR (n)

Placebo

4.8

5.0

0.0

4.8

+0.3

4.6

−0.1

4.0

−0.8

4.5–5.1 (n = 12)

4.0–5.3 (n = 12)

−0.5 to 0.5

4.4–5.4 (n = 9)

−0.4 to 0.8

4.2–5.3 (n = 8)

−0.7 to 0.6

3.1–5.1 (n = 6)

−1.9 to 0.6

L3-20

5.2

4.5a

−0.7

4.2

−0.9

4.5

−0.5

4.7

−0.6

4.7–5.6 (n = 13)

4.0–5.1 (n = 11)

−1.0 to −0.3

3.6–5.6 (n = 11)

−1.1 to 0.6

4.2–4.7 (n = 8)

−1.0 to 0.1

3.9–4.8 (n = 7)

−1.2 to −0.4

L3-40

5.3

4.3a

0.7b

4.1a

1.0b

4.5a

−0.4

4.3a

−0.6

4.9–5.4 (n = 11)

4.0–5.3 (n = 11)

−1.0 to −0.6

3.7–4.9 (n = 10)

−1.4 to −0.7

4.1–5.1 (n = 8)

−1.2 to 0.0

4.0–4.9 (n = 9)

−1.1 to -0.4

Fasting blood insulin (mmol/L), Median and IQR (n)

Placebo

11

12

+1

12

+2

11

0

11

+1

9–12 (n = 12)

10–15 (n = 12)

−2 to 4

8–19 (n = 9)

−3 to 10

8–6 (n = 8)

−3 to 8

10–14 (n = 6)

−1 to 2

L3-20

13

10

−2

10a

4b

9

−5

10

−3

12–16 (n = 13)

7–14 (n = 11)

−7 to 1

9–14 (n = 11)

−5 to −3

5–14 (n = 8)

−7 to −1

7–12 (n = 7)

−4 to 1

L3-40

10

10

−1

12

+1

12

+2

8

−1

9–13 (n = 11)

9–15 (n = 11)

−3 to 2

9–18 (n = 10)

−4 to 6

10–17 (n = 8)

−1 to 3

6–22 (n = 9)

−5 to 8

  1. Bold data indicate the presence of significantly different values.
  2. aSignificantly different from baseline.
  3. bSignificantly different from Placebo.